On-treatment biomarkers can improve prediction of response to neoadjuvant chemotherapy in breast cancer
Abstract Background Neoadjuvant chemotherapy is increasingly given preoperatively to shrink breast tumours prior to surgery. This approach also provides the opportunity to study the molecular changes associated with treatment and evaluate whether on-treatment sequential samples can improve response...
Main Authors: | Richard J. Bownes, Arran K. Turnbull, Carlos Martinez-Perez, David A. Cameron, Andrew H. Sims, Olga Oikonomidou |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-06-01
|
Series: | Breast Cancer Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13058-019-1159-3 |
Similar Items
-
Assessment of Predictive Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer
by: Mallika Tewari, et al.
Published: (2010-10-01) -
EARLY PREDICTION OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED BREAST CANCER USING MRI
by: NAGANAWA, SHINJI, et al.
Published: (2011) -
Oncological outcome of complete response after neoadjuvant chemotherapy for breast conserving surgery: a systematic review and meta-analysis
by: Xuan Li, et al.
Published: (2017-11-01) -
Neoadjuvant hormonal therapy is associated with comparable outcomes to neoadjuvant chemotherapy in post-menopausal women with estrogen receptor-positive breast cancer
by: David M. Marcus, et al.
Published: (2013-12-01) -
BRCA1 mRNA expression levels as an predictor of response to neoadjuvant chemotherapy in breast cancer
by: M. M. Tsyganov, et al.
Published: (2018-05-01)